Journal
/
/
Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Cancer Research
Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies
DOI:

09:53 min

November 30, 2016

, , , ,

Chapters

  • 00:05Title
  • 00:58Dissection and Dissociation of Patient-derived Xenograft (PDX)-derived Tumor Cells
  • 03:20Human Epithelial Cancer Cell Enrichment
  • 05:13PDX-derived Tumor Cell Transduction, Transduction Efficiency Evaluation and Tumor Cell Re-implantation
  • 06:48Results: PDX-dissociated Breast Cancer Cell Transduction Using High Titer Lentiviral Vectors
  • 08:33Conclusion

Summary

Automatic Translation

We describe a method for stable labeling of patient-derived xenografts (PDXs) with lentiviral particles expressing green-fluorescent protein and luciferase reporters. This method allows for tracking the growth of PDXs at the primary site, as well as detecting spontaneous and experimental metastases using in vivo imaging systems.

Related Videos

Read Article